Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis
Background There is no clear consensus on whether aspirin offers better outcomes in terms
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …
[PDF][PDF] Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis
D Liu, WP Xu, H Xu, L Zhao, DQ Jin - Frontiers in Cardiovascular …, 2023 - frontiersin.org
Background The benefits and risks of aspirin verse clopidogrel monotherapy in patients with
coronary artery disease (CAD) remain controversial. This meta-analysis evaluated the …
coronary artery disease (CAD) remain controversial. This meta-analysis evaluated the …
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials
TJ Helton, AA Bavry, DJ Kumbhani, S Duggal… - American journal of …, 2007 - Springer
Objectives To quantify the impact of clopidogrel plus aspirin on the individual outcomes of
death, myocardial infarction, or stroke in patients with established cardiovascular disease, or …
death, myocardial infarction, or stroke in patients with established cardiovascular disease, or …
Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis
YH Zhou, X Wei, J Lu, XF Ye, MJ Wu, JF Xu, YY Qin… - PLoS …, 2012 - journals.plos.org
Background Aspirin and clopidogrel monotherapies are effective treatments for preventing
vascular disease. However, new evidence has emerged regarding the use of combined …
vascular disease. However, new evidence has emerged regarding the use of combined …
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events
ADK Bowry, MA Brookhart, NK Choudhry - The American journal of …, 2008 - Elsevier
Antiplatelet agents are central to the treatment and prevention of cardiovascular disease.
Although aspirin is the most widely used agent, randomized trials have assessed whether …
Although aspirin is the most widely used agent, randomized trials have assessed whether …
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease
A Squizzato, T Keller… - Cochrane Database of …, 2007 - cochranelibrary.com
Background Aspirin is the prophylactic antiplatelet drug of choice for people with
cardiovascular disease. However, protection with antiplatelet therapy in people with a high …
cardiovascular disease. However, protection with antiplatelet therapy in people with a high …
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
A Squizzato, M Bellesini, A Takeda… - Cochrane Database …, 2017 - cochranelibrary.com
Background Aspirin is the prophylactic antiplatelet drug of choice for people with
cardiovascular disease. Adding a second antiplatelet drug to aspirin may produce additional …
cardiovascular disease. Adding a second antiplatelet drug to aspirin may produce additional …
Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials
S Palacio, RG Hart, LA Pearce, OR Benavente - Stroke, 2012 - Am Heart Assoc
Background and Purpose—In the Secondary Prevention of Small Subcortical Strokes
(SPS3) trial, addition of clopidogrel to aspirin was associated with an unexpected increase …
(SPS3) trial, addition of clopidogrel to aspirin was associated with an unexpected increase …
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
M Dennis, CAPRIE Steering Committee - The Lancet, 1996 - research.ed.ac.uk
BACKGROUND: Many clinical trials have evaluated the benefit of long-term use of
antiplatelet drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine …
antiplatelet drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine …
Clopidogrel: the data, the experience, and the controversies
S Sadanandan, IM Singh - American Journal of Cardiovascular Drugs, 2012 - Springer
Dual antiplatelet therapy with acetylsalicylic acid (aspirin) and clopidogrel is a guideline-
recommended standard of care for patients with acute coronary syndromes (ACS) and those …
recommended standard of care for patients with acute coronary syndromes (ACS) and those …